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Abstract
Background: To investigate the impact of previous ovarian surgery on ovarian reserve in patients with endometriosis.
Methods: A total of 829 female patients were recruited. Their medical records were reviewed retrospectively. Patients
who had diagnoses of endometriosis or endometrioma were defined as the endometriosis group, and those without
endometriosis were as the control group. We further divided these patients into four groups according to whether
they had received ovarian surgeries before. Group 1: control group without previous surgery; Group 2: control group
with previous surgery; Group 3: endometriosis group without previous surgery; Group 4: endometriosis group with
previous surgery. The subgroups with endometrioma or not and different operative procedures were also analyzed.
The parameters for comparison included age, body mass index, serum estradiol, follicle-stimulating hormone,
luteinizing hormone, cancer antigen 125, and anti-Müllerian hormone (AMH) level.
Results: The level of serum AMH was highest in group 1 and lowest in group 4. The decline was significant between
group 1 and group 4 (p < 0.05). The serum AMH level was lower in group 4 than in group 3 but no significant
difference. Serum estradiol level was significantly higher in group 3 than in group 2 (p < 0.05). Cancer antigen 125
levels were both significantly higher in group 3 and group 4 as compared with group 1 and group 2 (p < 0.05).
Conclusions: Performing repeated ovarian surgery in patients with recurrent endometriosis needs careful
consideration and adequate patient counselling because of the predictable deteriorating ovarian reserve.
Background
Anti-Müllerian hormone (AMH) is secreted by pre-antral
and antral follicles [1]. Unlike those predictors of ovarian
reserve, e.g. basal follicle-stimulating hormone, estradiol,
inhibin B, and antral follicle counts, a number of previous
studies demonstrated AMH was a steadier marker to
predict residual ovarian function (i.e. not being obviously
influenced by menstruation) [2–5]. Changes in serum
AMH level in patients with endometriosis have been well-
documented. Remarkable declines in serum AMH were
reported in patients with moderate to severe endometriosis,
especially in those with bilateral endometriomas [6–12].
However, the impact of ovarian surgery on ovarian re-
serve in patients with endometriosis is still controversial.
Some studies have reported decreased level of serum AMH
after ovarian surgery [12–26], while others have reported
steady serum AMH levels after ovarian surgery [27–30]. It
is difficult to make definite conclusions due to selection
bias of the study populations, surgeons’ expertise and skills,
differences in the surgical techniques, and selected out-
comes [31, 32]. In addition, the case numbers of these stud-
ies are also limited.
Patients with endometriosis usually receive ovarian
surgery for disease treatment, symptomatic relief, and
conception [33, 34]. At the out-patient department, clini-
cians often encounter this question: whether underlying
endometriosis or previous ovarian surgery plays a more
important role for the poor serum AMH level in patients
with endometriosis. In addition, these patients with endo-
metriosis may be referred from other hospitals, operated
by different surgeons, and received different procedures.
Therefore, the impact of previous ovarian surgery on ovar-
ian reserve is difficult to estimate.
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In this study, we tried to collect more numbers of pa-
tients with endometriosis than current publications in the
out-patient setting, and performed a retrospective cohort
study regardless of inter-surgeon variability to evaluate the
impact of previous ovarian surgery on their ovarian reserve.
Methods
Patient enrollment and assignment
All of the patients were collected from December 2010 to
June 2012 at the out-patient department of Obstetrics and
Gynecology in Chang Gung Memorial Hospital, Kaohsiung
Medical Center in Taiwan. To evaluate the impact of endo-
metriosis and previous ovarian surgery on ovarian reserve,
we focused on reproductive female patients. The inclusion
criteria were: (1) female patients with regular menstrual
cycles (interval within 25 to 35 days); and (2) female
patients who had available blood samples of serum AMH
at Chang Gung Memorial Hospital, Kaohsiung Medical
Center. The exclusion criteria were: (1) male patients; (2)
female patients who had not yet experienced menarche or
who had reached menopause; and (3) female patients who
were diagnosed with premature ovarian failure. All of their
charts were retrospectively reviewed by a physician and a
gynecologist, including out-patient department records,
admission note, discharge note, transfer note, laboratory
data, previous operative records, pelvic examination, and
ultrasound findings. According to their medical records,
the patients who had endometriosis or endometrioma were
assigned into the endometriosis group, and those without
endometriosis into the control group. In order to test our
hypothesis that previous ovarian surgery may exacerbate
ovarian reserve in patients with endometriosis, the endo-
metriosis and control groups were further divided
into four groups: group 1: patients without endomet-
riosis had no history of ovarian surgery; group 2: pa-
tients without endometriosis had experienced ovarian
survey before this clinical visiting; group 3: patients
with endometriosis had no history of ovarian surgery;
and group 4: patient with endometriosis had under-
gone ovarian surgery prior to this visiting.
In terms of the effects of endometrioma, we further
divided the endometriosis group (group 3 and group 4) into
subgroups with endometrioma or not, presented as follow-
ing: subgroup A: endometriosis patients neither had history
of ovarian surgery nor endometrioma; subgroup B: endo-
metriosis patients without history of ovarian surgery had
endometrioma; subgroup C: endometriosis patients had
undergone ovarian surgery without endometrioma; sub-
group D: endometriosis patients had both ovarian surgery
history and endometrioma.
In our study, the minimal interval between the last sur-
gery and clinical visiting were 3 months, and we thought it
is reasonable to eradicate the immediate influence of
serum AMH level after ovarian surgery. Different operative
surgeons, procedures (laparotomy or laparoscopy, cystec-
tomy, vaporization, combined cystectomy and vaporization,
and only drainage) and lesions (ovarian endometrioma,
endometriosis, teratoma or cyst) were all included in the
previous ovarian surgery group. To discriminate the effect
of different operative procedures in patients with endomet-
riosis, the subgroups with different operative procedures,
such as cystectomy, vaporization, combined cystec-
tomy and vaporization, and only drainage were separ-
ately evaluated.
The Institutional Review Board of the Ethics Committee
of Chang Gung Memorial Hospital approved this study
(102-4853B). The need for consent was waived by the IRB.
Laboratory assessments
All patients had available serum AMH data, and other pa-
rameters including age, body mass index (BMI), serum xes-
tradiol (E2), follicle-stimulating hormone (FSH), luteinizing
hormone (LH), and cancer antigen 125 (CA-125) were also
assessed. All of the parameters were compared among
these four groups.
The timing of blood sampling depended upon when the
patients presented at the outpatient department and their
recent menstruation. When the patients visited the out-
patient department, serum AMH levels were obtained,
regardless of the menstrual phase, by a commercial
enzyme-linked immunosorbent assay kit (ELISA, Beckman
Coulter, USA). The limit of the detectable level of AMH
was 0.1 ng/ml, and the intra-assay and inter-assay coeffi-
cients of variation were 5.3 and 8.7 % respectively.
Other serum hormones were assessed in the early fol-
licular phase of the menstrual cycle by commercially avail-
able immunoassay systems (ADVIA Centaur, Siemens,
USA). The detection limits were 11.8 pg/ml for E2, 0.3
mIU/ml for FSH, and 0.07 mIU/ml for LH. CA-125 level
was checked with the Architect CA 125 II assay (Abbott
Diagnostics, USA), and the detection limit was 1.0 U/ml.
All the serum samples were immediately separated by
centrifugation at 4 °C for 15 min and stored at −80 °C
until assay.
Statistics
Statistical analyses were performed using SPSS (ver. 19.0;
Statistical Package for Social Sciences, Inc., Chicago, IL,
USA). Statistical evaluation of four groups was performed
by one-way analysis of variance (ANOVA) with Bonferroni
test for post hoc analysis. Continuous data are summarized
as mean ± standard deviation. A probability values < 0.05
was considered statistically significant.
Results
A total of 957 patients with available serum AMH data
were collected. After 128 patients were excluded, the
remaining 829 female patients were enrolled into this study.
Chiang et al. BMC Women's Health  (2015) 15:74 Page 2 of 8
Among them, there were 209 (25.2 %) patients allocated in
the endometriosis group, and 620 (74.8 %) patients in the
control group. The endometriosis group and control group
were further divided into four groups based on if previous
ovarian surgery: group 1: the patients had no ovarian sur-
gery in control group (n = 496), group 2: the patients with
previous ovarian surgery in control group (n = 124), group
3: the patients had no ovarian surgery in endometriosis
group (n = 76), group 4: the patients with previous ovarian
surgery in endometriosis group (n = 133) (Fig. 1).
The period between blood sampling time and their
previous surgery were ranged from three to twenty-four
months, and the median of post-surgical months were
ten months.
When comparing the parameters among the four
groups, no significant differences were found in age, BMI,
FSH, and LH (Table 1). However, a trend of decreasing
serum AMH from group 1 to group 4 was noticeable. The
highest serum AMH level was shown in group 1 and the
lowest one was in group 4. The difference was statistically
significant between them (4.2 ± 2.0 vs 2.3 ± 1.0 ng/ml,
p < 0.05). Besides, the lower serum AMH level was noted
in group 3 than in group 4, although not reaching signifi-
cant difference.
Serum E2 level was significantly higher in group 3 than
in group 2 (31.3 ± 17.0 vs 20.2 ± 12.3 pg/ml, p < 0.05). CA-
125 level were both significantly higher in group 3 and
group 4 as compared with group 1 and group 2 (40.9 ±
27.4, 45.3 ± 29.8 vs 18.6 ± 12.9, 22.2 ± 13.6 ng/ml, p < 0.05)
(Table 1) (Fig. 2).
The endometriosis group (group 3 and group 4) were
further divided into 4 subgroups according to whether
endometrioma was diagnosed or not: subgroup A:
patients xhad history of neither ovarian surgery nor
endometrioma (n = 53); subgroup B: patients without
history of ovarian surgery had endometrioma (n = 23);
subgroup C: patients undergoing ovarian surgery with-
out endometrioma (n = 95); subgroup D: patients had
both ovarian surgery history and endometrioma (n = 38)
(Fig. 1). When comparing the parameters among them,
Fig. 1 Patients enrollment flowchart
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there was no significant difference, although lower serum
AMH and higher CA-125 were noted in endometrioma
subgroup (Table 2).
In different operative procedure subgroups of endo-
metriosis patients, there were twenty patients received
cystectomy, ninety-five patients received vaporization,
fifteen patients received combined cystectomy and
vaporization, and three patients received drainage only.
The comparison of parameters among them showed no
significant difference, although higher serum AMH and
CA-125 were noted in combined cystectomy and
vaporization subgroup (Table 3).
Table 1 Clinical characteristics of 4 groups









Number 496 124 76 133
Age (years) 35.1 ± 5.9 36.1 ± 5.1 34.0 ± 5.0 35.3 ± 3.7 NS
BMI (kg/m2) 22.0 ± 3.8 22.6 ± 3.7 21.5 ± 3.4 22.1 ± 3.3 NS
E2 (pg/mL) 28.1 ± 13.5 20.2 ± 12.3 31.3 ± 17.0 24.4 ± 12.0 <0.05
FSH (mIU/mL) 6.2 ± 3.1 5.8 ± 3.0 6.0 ± 3.5 7.1 ± 3.5 NS
LH (mIU/mL) 5.5 ± 3.2 6.1 ± 3.6 3.7 ± 2.4 6.2 ± 3.8 NS
AMH (ng/mL) 4.2 ± 2.0 3.1 ± 2.0 3.1 ± 1.8 2.3 ± 1.0 <0.05
CA-125 (U/mL) 18.6 ± 12.9 22.2 ± 13.6 40.9 ± 27.4 45.3 ± 29.8 <0.05
BMI body mass index, E2 serum estradiol, FSH follicle-stimulating hormone, LH luteinizing hormone, AMH anti-Müllerian hormone, CA-125 cancer antigen 125,
NS not significant (p > 0.05)
aAnalysis of variance (ANOVA) with repeated measures
Fig. 2 Parameters for comparison among 4 groups. (a) age (b) BMI: body mass index, (c) E2: serum estradiol, (d) FSH: follicle-stimulating hormone,
(e) LH: luteinizing hormone, (f) AMH: anti-Müllerian hormone, (g) CA-125: cancer antigen 125. *, § = statistical significance (p < 0.05)
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As for distribution of causes of infertility in our patient
groups, 412 (49.7 %) patients had primary infertility, 249
(30.0 %) patients had secondary infertility, and the remain-
der had no infertile problems (20.4 %).
Discussion
According to our analysis, more than half of the endometri-
osis patients in this study (133/209, 63.6 %) had previously
received ovarian surgery before they visited our out-patient
department. Therefore, the effect of previous ovarian sur-
gery on their ovarian reserve was worthy to be investigated.
There was a noticeable trend of decreasing serum AMH
from control group to endometriosis group. Lower serum
AMH level was shown in endometriosis group with previ-
ous ovarian surgery, as compared with the endometriosis
group without ovarian surgery, although it didn’t reach a
statistical significance. It reflected that the attenuation of
ovarian reserve after ovarian surgery should not be under-
estimated, especially in patients with endometriosis. This
result supported our hypothesis that superimposed ovarian
damage from previous surgery on pre-existing or recurrent
endometriosis caused most remarkable deterioration of
ovarian reserve.
Such as what had been well-recognized in several
studies, we also found that previous ovarian surgery or
endometriosis moderately decreased ovarian reserve, re-
spectively [6–12]. Although there was no significant dif-
ference of serum AMH level between these two groups
in this study.
Prior studies have analyzed pre- and post-operative
serum AMH levels in patients with endometriosis [12–29].
However, these studies have been limited by the small num-
ber of patients, and definite conclusions have been difficult
to make due to different surgeons and procedures [31].
Our study was closer to real world consideration, in-
cluded the patients from the out-patient department,
and enrolled more patient numbers than previous stud-
ies, no matter what ovarian surgeries were performed at
different hospitals, by different surgeons and with dif-
ferent procedures. Our finding may suggest that
Table 2 Clinical characteristics of endometriosis subgroups with endometrioma or not
Subgroup A Subgroup B Subgroup C Subgroup D p valuea
No ovarian surgery No ovarian surgery Previous ovarian surgery Previous ovarian surgery
No endometrioma With endometrioma No endometrioma With endometrioma
Number 53 23 95 38
Age (years) 34.5 ± 5.5 32.8 ± 3.5 35.4 ± 3.6 34.9 ± 4.1 NS
BMI (kg/m2) 21.8 ± 3.6 20.9 ± 3.1 22.1 ± 3.6 22.2 ± 2.8 NS
E2 (pg/mL) 31.4 ± 25.7 31.0 ± 22.0 23.4 ± 18.9 27.4 ± 20.2 NS
FSH (mIU/mL) 6.3 ± 3.8 5.2 ± 2.1 7.2 ± 3.6 6.9 ± 3.3 NS
LH (mIU/mL) 3.8 ± 1.6 3.5 ± 1.4 6.5 ± 2.4 5.1 ± 2.9 NS
AMH (ng/mL) 3.3 ± 2.3 2.6 ± 2.0 2.3 ± 1.9 2.4 ± 1.6 NS
CA-125 (U/mL) 33.2 ± 23.1 50.7 ± 29.8 43.5 ± 27.3 48.6 ± 20.5 NS
BMI body mass index, E2 serum estradiol, FSH follicle-stimulating hormone, LH luteinizing hormone, AMH anti-Müllerian hormone, CA-125 cancer antigen 125,
NS not significant (p > 0.05)
aAnalysis of variance (ANOVA) with repeated measures
Table 3 Clinical characteristics of different surgical procedure subgroups in patients with endometriosis
Cystectomy Vaporization Combined cystectomy
and vaporization
Drainage p valuea
Number 20 95 15 3
Age (years) 34.9 ± 4.5 35.4 ± 3.6 34.4 ± 3.7 37.7 ± 4.1 NS
BMI (kg/m2) 22.7 ± 2.0 22.1 ± 3.6 21.5 ± 3.7 22.1 ± 2.6 NS
E2 (pg/mL) 29.4 ± 14.6 23.4 ± 10.9 23.5 ± 19.3 29.4 ± 14.5 NS
FSH (mIU/mL) 6.9 ± 3.1 7.2 ± 3.6 7.1 ± 2.0 6.7 ± 1.6 NS
LH (mIU/mL) 5.2 ± 3.0 6.5 ± 4.4 4.2 ± 2.7 6.6 ± 4.0 NS
AMH (ng/mL) 2.3 ± 1.4 2.3 ± 1.9 2.6 ± 1.6 1.6 ± 1.0 NS
CA-125 (U/mL) 37.4 ± 21.0 43.5 ± 27.3 46.2 ± 28.2 37.2 ± 15.0 NS
BMI body mass index, E2 serum estradiol, FSH follicle-stimulating hormone, LH luteinizing hormone, AMH anti-Müllerian hormone, CA-125 cancer antigen 125,
NS not significant (p > 0.05)
aAnalysis of variance (ANOVA) with repeated measures
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previous ovarian surgery exacerbates the depletion of
ovarian reserve in the patients with endometriosis re-
gardless of inter-surgeon variability. The impact of ovar-
ian surgery on ovarian reserve in patients with
endometriosis should not be neglected. Moreover, it
strengthens the findings of prior studies that serum AMH
level decreases immediately after ovarian surgery and was
continuously lower in serial follow-up [12–26].
It has been known that elevated serum estradiol in early
follicular phase predicts poor ovarian response when
undergoing in vitro fertilization [35–37]. In this study, we
found that the serum estradiol was significantly highest in
endometriosis group without previous ovarian surgery
and lowest in control group with previous ovarian surgery.
It denotes that the patients had endometriosis without any
management would have poor ovarian response during in
vitro fertilization. Furthermore, patients who received pre-
vious ovarian surgery for benign ovarian diseases other
than endometriosis, would improve their ovarian response
when undergoing in vitro fertilization.
Besides, the significant higher CA-125 level in all endo-
metriosis groups than control groups supports the applica-
tion of CA-125 in the clinical diagnosis of patients with
endometriosis [38, 39].
Prior studies have reported that the existence of endo-
metrioma would attenuate pre-operative serum AMH
[8, 10, 12], and the post-operative serum AMH signifi-
cantly decreased in women with prior endometrioma
surgery [11, 14, 17–21, 26]. Different operative proce-
dures also affected the ovarian reserve [15, 23–25, 34].
However, as for patients with endometriosis in this
study, the impacts of diagnosis of endometrioma and
different operative procedures on serum AMH level
were not significant. The findings were consistent with
some studies that mentioned the post-operative de-
crease of ovarian reserve was not significant at the end
of three-month follow-up and also limited in experi-
enced surgeons’ hands [27–30, 40]. Therefore, the pos-
sible explanation would be that the larger pooled
patient number and longer post-operative period (ran-
ging from three to twenty-four months, and the median
period was ten months) diminished the influence from
endometrioma and different operative procedures.
The finding of our study is very useful for evaluating a
patient coming to clinic for infertility counselling. A clin-
ician should always consider impact of previous surgery
on current condition of ovarian reserve, especially in those
patients with diagnoses of endometriosis [41]. Very low
serum AMH level on biochemistry implies further surgical
intervention may not be the first choice for an infertile
endometriosis patient, under the consideration of insuffi-
cient ovarian reserve [42–44].
In the current studies investigating the relationship be-
tween ovarian reserve and endometriosis, more and more
clinical evidence proved that the post-operative deteriorat-
ing of ovarian reserve was remarkable [12, 24–26]. The
trend of treatment of endometriosis was gradually towards
conservative and individualized, especially for the patients
with fertile desire [42–44]. Our findings highlighted the
impact of previous ovarian surgeries on ovarian reserve in
patients with endometriosis at the out-patient department,
despite different operative procedures and inter-surgeon
variability. It emphasized the current attitude toward the
management of endometriosis with a new perspective
from the out-patient department.
Nevertheless, these findings should be interpreted with
caution because the impact of the different operative proce-
dures, lesions, and surgeons on ovarian reserve may have
ranged from mild to severe. The decreases in serum AMH
level also varied considerably. When explaining the risk of
surgery on ovarian reserve to patients, it must be done on
an individual basis to take their clinical condition into
account [44].
There are several limitations to this study. First, the inter-
val from previous ovarian surgery to obtaining the level of
serum AMH varied, and it is known that the level of serum
AMH changes during the post-operative period from
1 week to 9 months [13–23, 27–29]. We checked the
serum AMH level on the patient’s visiting the out-patient
department, however the interval from visiting to their
previous ovarian surgery ranged from three to twenty-
four months, and this may have affected our results.
Second, data on the staging and revised American
Fertility Society (r-AFS) classification [45] of endometri-
osis in our patients were incomplete, because some pa-
tients’ surgical records from other hospitals had not
been obtained at that time. Relevant data was insuffi-
cient to evaluate previous surgical impact on ovarian
reserve in different endometriosis staging.
Further studies are warranted to investigate the impact of
previous surgery on the outcomes of assisted reproductive
technology in patients with endometriosis. And further
analysis of the impact of previous ovarian surgery on ovar-
ian reserve in patients with different endometriosis staging,
as well as the association between the change of serum
AMH and benign ovarian diseases other than endometri-
osis will be further elucidated in the future.
Conclusions
History of endometriosis and previous ovarian surgery
offer clinicians useful information regarding ovarian
reserve. Performing repeated ovarian surgery in patients
with recurrent endometriosis needs careful consideration
and adequate patient counselling because of the predict-
able deteriorating ovarian reserve.
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